Total amount raised
$19 Millions
Latest funding date
9/1/2023
Location
Evvy has successfully raised $14 million in its Series A funding round, attracting the attention of notable investors like Amboy Street Ventures and LabCorp Venture Fund. The company specializes in at-home vaginal microbiome tests, leveraging metagenomic sequencing to address critical health challenges.
Keep reading to explore the intricacies of Evvy's fundraising journey and the investors backing this innovative platform.
What Is Evvy?
Evvy, founded in 2020 by Laine Bruzek, Pita Navarro, and Priyanka Jain, is based in New York, New York. The company specializes in at-home vaginal microbiome tests, utilizing metagenomic sequencing to provide personalized health insights.
With a mission to close the gender health gap, Evvy offers a range of services including a Vaginal Microbiome Test, Prescription Treatment Program, and 1:1 Health Coaching. Their innovative approach aims to improve female health by understanding symptoms and risks for critical health challenges.
Evvy employs a team of 11-50 dedicated professionals, working together to bring precision care to vaginal health. Their commitment to innovation and personalized treatment plans sets them apart in the healthcare industry.
How Much Funding Has Evvy Raised?
- Seed Round
- Amount Raised: $5M
- Date: July 2021
- Lead Investors: General Catalyst
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To launch their at-home vaginal microbiome test and build a comprehensive dataset on the vaginal microbiome.
- Series A
- Amount Raised: $14M
- Date: September 2023
- Lead Investors: Left Lane Capital
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To scale access to Evvy's testing and care platform, leverage AI for discovering novel molecular signatures, and validate improved outcomes in fertility and pregnancy.
Total Amount Raised: $19M. Current Valuation: Not publicly disclosed.
Key Investors
- Left Lane Capital
- Details: Left Lane Capital is a venture capital firm that focuses on high-growth consumer internet and technology companies. They led Evvy's $14 million Series A funding round.
- Investment Focus Areas: Consumer internet, technology, high-growth startups.
- Notable Investments: GoPuff, Tovala.
- General Catalyst
- Details: General Catalyst is a venture capital firm that invests in early-stage and growth equity companies. They participated in both Evvy's seed and Series A funding rounds.
- Investment Focus Areas: Technology, healthcare, consumer products.
- Notable Investments: Airbnb, Stripe, Snap.
- Labcorp Venture Fund
- Details: Labcorp Venture Fund is the venture arm of Labcorp, a global life sciences company. They invest in companies that align with Labcorp's mission to improve health and lives.
- Investment Focus Areas: Life sciences, healthcare, diagnostics.
- Notable Investments: Specific notable investments are not mentioned.
- RH Capital
- Details: RH Capital focuses on reproductive and maternal health innovations. They participated in Evvy's Series A funding round.
- Investment Focus Areas: Reproductive health, maternal health, women's health.
- Notable Investments: Ovia Health, Maven Clinic.
- Amboy Street Ventures
- Details: Amboy Street Ventures invests in companies that address women's health and sexual wellness. They participated in Evvy's Series A funding round.
- Investment Focus Areas: Women's health, sexual wellness, healthcare technology.
- Notable Investments: Specific notable investments are not mentioned.
What's Next for Evvy?
Evvy stands at the cusp of a transformative journey in women's healthcare. With the recent $14 million Series A funding, the company is poised to scale its testing and care platform, leveraging AI to discover novel molecular signatures. This expansion could significantly impact areas like fertility and pregnancy, offering comprehensive solutions that integrate STI and antibiotic resistance testing.
As Evvy continues to grow, future fundraising opportunities seem likely, especially given the increasing focus on precision healthcare and personalized medicine. However, the company will need to navigate challenges such as ensuring the accuracy of at-home tests and meeting regulatory requirements. Competing with established healthcare providers and maintaining high-quality care will also be crucial as they scale operations.
Use Clay to Get Funding Data
Sales professionals, take your strategy to the next level by leveraging Clay's platform to access comprehensive fundraising data on companies like Evvy and gather other critical business insights.
Sign up for free on Clay today and unlock the potential to drive your sales success.
